Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
Healthcare
Biotechnology
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 25, 2024 11:07am
7,340,000 million .20 warrants have expired unexercised
August 25, 2024 0.20 2,000,000 September 19, 2024 0.20 1,350,000 November 10, 2024
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Post by
Hideaway
on Nov 23, 2024 12:12pm
NR
VANCOUVER, BC , Nov. 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it intends to
...more
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 22, 2024 4:10pm
3/4 million shares traded today not including OTC US$
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr ATS 184.0 0.06 · 0.065
...more
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 22, 2024 3:53pm
Level 2 bid ask
Ask 0.085 29,000 3 0.08 26,000 4 0.075 72,000 5 0.07 317,900 5 0
...more
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 22, 2024 3:48pm
Tech chart with accumulation distribution
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 22, 2024 3:40pm
Tech chart (accumulation stage) 30 day moving avg crosses 60
(19)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on Nov 22, 2024 2:42pm
RE:Pfizer was once criticized for lack of vaccine development
What excites me is the many possible products that can be developed over time. This has a multiple earnings growth potential. I will be adding some trading shares by year-end as I said before. However
...more
(9)
•••
GoldCanuck28
X
View Profile
View Bullboard History
Post by
GoldCanuck28
on Nov 22, 2024 2:24pm
SpayVac
https://stockhouse.com/news/press-releases/2024/11/20/biovaxys-partner-spayvac-for-wildlife-inc-scales-up-vaccine-production-capacity
(9)
•••
GoldCanuck28
X
View Profile
View Bullboard History
Comment by
GoldCanuck28
on Nov 22, 2024 2:20pm
RE:Pfizer was once criticized for lack of vaccine development
Yes, so excited for this diversification of BIOV. To the moon...
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 22, 2024 2:05pm
1/2 million shares CDN traded so far/ Not including OTC US
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr ATS 107.6 0.065 ·
...more
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 22, 2024 1:49pm
Look at the weakness at .075 .08 .085 /wall at .09
0.085 44,000 4 0.08 26,000 4 0.075 74,000 6 0.07 348,900 5 Bid 0
...more
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 22, 2024 1:15pm
If you wnt to sell into the bid TD just placed a 338k buy
Bid Ask Broker Size Price Price Size Broker 39 Merrill Lynch 3,200 0.065
...more
(19)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 21, 2024 11:26am
5.9 million shs traded on U.S. $ OTC last 10 days BVAXF
volume 431,451 316,498 319,342 191,900 965,380 1,222,160 1,112,740 157,016
...more
(298)
•••
moneywagon
X
View Profile
View Bullboard History
Comment by
moneywagon
on Nov 21, 2024 11:08am
RE:Pfizer was once criticized for lack of vaccine development
rich47 welcome I give your new member name the 1ST star for sharing your dd. You may have a new member name but uhhhh mei thinks your a well seasoned wine/investor!! lol LETS GOOOoooooooo BIOV
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Webinar Dec. 12, 2024: Transforming Regenerative Medicine. Register Now
Do you want to stay ahead of the markets? See how DealRoom can help.
Why Dozens of Pro Athletes are Paying Attention to this Product
Q Precious & Battery Metals To Resume Diamond Drilling La Corne South Project, Val D'or Quebec